Table 1. Subjects´ and diseases´ characteristics at baseline.
| Variables | IC group n = 91 |
UC group n = 80 |
P-value | |
|---|---|---|---|---|
| Age, years, Mean (SD) | 73.6 (9.2) | 72.2 (9.4) | 0.38 | |
| Sex, n (%) | Male | 39 (42.9) | 34 (42.5) | 0.96 |
| Female | 52 (57.1) | 46 (57.5) | ||
| BMI, kg/m2, Mean (SD) | 22.7 (5.2) | 23.5 (6.0) | 0.55 | |
| FEV1 L/sec, Mean (SD) | 0.86 (0.36) | 0.84 (0.33) | 0.68 | |
| FEV1%, Mean (SD) | 33.6 (9.9) | 33.4 (9.4) | 0.92 | |
| GOLD3, n (%) | 54 (59.3) | 46 (58.5) | 0.81 | |
| GOLD 4, n (%) | 37 (40.7) | 34 (42.5) | ||
| Hospital admissions (number) year prior study: | 1 | 60 (65.9) | 46 (57.5) | 0.26 |
| 2–3 | 23 (25.3) | 23 (28.8) | 0.61 | |
| ≥4 | 8 (8.8) | 11 (13.8) | 0.30 | |
| Living alone n (%) | 47 (51.6) | 38 (47.5) | 0.58 | |
| Current smokers, n (%) | 30 (33.0) | 32 (40.0) | 0.46 | |
| Receiving home care, n (%) | 51 (56.0) | 41 (51.3) | 0.53 | |
| Charlson co morbidity Index | 1–3 | 18 (19.8) | 18 (22.5) | 0.87 |
| 4–6 | 57 (62.6) | 47 (58.8) | ||
| 7–10 | 16 (17.6) | 15 (18.8) | ||
| Inhaled medication, n (%) | LAMA | 20 (39.2) | 25(51) | 0.2 |
| LABA+ICS | 36 (70.6) | 35 (71.4) | 0.9 |
IC: integrated care; UC: usual care; BMI: body mass index; FEV1: forced expiratory volume in one second; FEV1%: FEV1% of predicted value; HA: hospital admission due to AECOPD one year prior study start; LAMA: long –acting muscarinic receptor antagonist; LABA: Long- acting β2-agonist; ICS: inhaled Corticosteroids.